Summary

The global GMP (Good Manufacturing Practice) testing service market is witnessing significant momentum as regulatory compliance, quality control, and product validation continue to play an integral role in pharmaceutical and medical device production. As industries strive to meet international standards, GMP testing services have become essential to ensure the safety, efficacy, and consistency of medical products. According to a new industry analysis, the GMP testing service market is projected to rise from a valuation of US$ 2.2 billion in 2025 to US$ 3.4 billion by 2032, registering a CAGR of 6.42% over the forecast period.

Market Insights

GMP testing services are vital for ensuring that pharmaceutical drugs and medical devices meet regulatory standards and are safe for public use. The market has grown in response to the rising complexity of drug formulations and the increasing prevalence of chronic diseases requiring advanced therapies. As quality assurance becomes a non-negotiable priority in manufacturing processes, GMP services such as product validation, bioanalytical testing, packaging and shelf-life analysis are seeing growing demand across various sectors.

The market is increasingly driven by heightened awareness around patient safety, the need to reduce product recalls, and greater scrutiny by regulatory bodies. With more novel and specialty drugs entering the pipeline, there is an amplified emphasis on thorough testing protocols, thereby enhancing the importance of GMP services globally.

Market Drivers

One of the key drivers of growth in the GMP testing service market is the rising demand for medical devices. The medical device sector produces a wide range of items, from essential diagnostic tools to advanced therapeutic instruments. Devices such as oxygen concentrators, insulin pumps, and portable diagnostic kits are increasingly used both in clinical settings and at home, necessitating rigorous quality and safety checks that align with GMP standards.

Additionally, the rapid growth in pharmaceutical and biopharmaceutical innovation is fueling market expansion. These industries require extensive testing to validate new therapies and comply with national and international regulations. With diseases like cancer, diabetes, and cardiovascular conditions affecting millions globally, drug developers are under pressure to fast-track development while ensuring high-quality outcomes—driving demand for specialized GMP testing services.

The rising popularity of smart medical devices integrated with IoMT (Internet of Medical Things) platforms also contributes to the increasing need for testing services that maintain safety, performance, and consistency. GMP compliance helps manufacturers mitigate risks related to product failure, contamination, and variability, which can otherwise lead to costly litigations and brand damage.

Business Opportunity

Despite facing regulatory challenges, the GMP testing service market presents substantial business opportunities, particularly in emerging economies. The expansion of pharmaceutical manufacturing facilities in countries like India, China, and Brazil is expected to open new avenues for service providers.

Contract manufacturing and outsourcing trends are also boosting demand for third-party GMP testing labs. With many pharmaceutical and device manufacturers opting for external partners for testing and validation, service providers stand to gain from increased outsourcing. Furthermore, the global push towards harmonizing GMP standards offers an opportunity for service providers to create integrated testing platforms that cater to multiple regulatory bodies, enhancing their market footprint.

Innovations in analytical technologies, including real-time testing, AI-assisted quality control, and automated validation processes, are further reshaping the market. Companies investing in such technologies are well-positioned to tap into new revenue streams and build long-term partnerships with manufacturers.

Regional Analysis

The global GMP testing service market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America currently holds the leading share, driven by a strong regulatory environment, widespread adoption of cutting-edge healthcare technologies, and a well-established infrastructure for drug manufacturing.

The United States continues to be a lucrative market, supported by a high number of FDA-approved manufacturing facilities and strong R&D investment in pharmaceutical development. Funding initiatives from institutions such as the National Institutes of Health (NIH) and a growing pipeline of new drugs are creating robust demand for GMP services.

Europe follows closely, benefiting from the presence of multiple pharmaceutical hubs and stringent EU regulatory frameworks. Germany, the UK, and France are prominent contributors to regional growth.

Asia Pacific is anticipated to emerge as a high-growth region, propelled by the increasing number of contract manufacturing organizations (CMOs), rising healthcare expenditures, and evolving regulatory frameworks. Countries like China and India are investing in upgrading their pharmaceutical manufacturing capabilities, making them attractive destinations for outsourced GMP testing.

Key Players

The competitive Analysis of the GMP testing service market is marked by the presence of several global and regional players offering a broad range of testing services. Leading companies are focusing on expanding their global footprint, forming strategic partnerships, and enhancing technological capabilities to cater to rising demand.

Some of the key players operating in the market include:

• Eurofins Scientific

• North American Science Associates Inc.

• Almac Group

• PPD Inc.

• Intertek Group PLC

• Nelson Laboratories LLC

• Wuxi AppTec

• Sartorius AG

• Boston Analyticals

• Pace Analyticals

These companies are actively engaging in acquisitions and collaborations to boost their service offerings and geographical presence. For example, Almac Diagnostic Services signed a Master Collaboration Agreement with AstraZeneca for the development of companion diagnostic products. Similarly, Eurofins expanded its GMP testing capabilities in Japan with the acquisition of Astellas Analytical Science Laboratories.

Segmentation

The GMP testing service market is segmented based on service type, end user, and region.

By Service Type

• Product Validation Testing

• Bioanalytical Services

• Packaging and Shelf-Life Testing

• Other Services

Among these, product validation testing leads the market and is expected to continue witnessing high growth owing to increasing demand for validation across drug development and manufacturing processes.

By End User

• Pharmaceutical and Biopharmaceutical Companies

• Medical Device Companies

Pharmaceutical and biopharmaceutical companies represent the largest end-user segment due to their extensive involvement in drug discovery, clinical trials, and large-scale manufacturing. The need to meet stringent quality standards and regulatory compliance significantly drives their reliance on GMP testing services.

By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global GMP Testing Service Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global GMP Testing Service Market Outlook, 2019-2032
3.1. Global GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Product Validation Testing
3.1.1.2. Bioanalytical Services
3.1.1.3. Packaging & Shelf-Life Testing
3.1.1.4. Other Services Type
3.2. Global GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Pharmaceutical and Biopharmaceutical Companies
3.2.1.2. Medical Device Companies
3.3. Global GMP Testing Service Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America GMP Testing Service Market Outlook, 2019-2032
4.1. North America GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Product Validation Testing
4.1.1.2. Bioanalytical Services
4.1.1.3. Packaging & Shelf-Life Testing
4.1.1.4. Other Services Type
4.2. North America GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Pharmaceutical and Biopharmaceutical Companies
4.2.1.2. Medical Device Companies
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. U.S. GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
4.3.1.2. U.S. GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
4.3.1.3. Canada GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
4.3.1.4. Canada GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe GMP Testing Service Market Outlook, 2019-2032
5.1. Europe GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Product Validation Testing
5.1.1.2. Bioanalytical Services
5.1.1.3. Packaging & Shelf-Life Testing
5.1.1.4. Other Services Type
5.2. Europe GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Pharmaceutical and Biopharmaceutical Companies
5.2.1.2. Medical Device Companies
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Germany GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.2. Germany GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.3. U.K. GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.4. U.K. GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.5. France GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.6. France GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.7. Italy GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.8. Italy GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.9. Turkey GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.10. Turkey GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.11. Russia GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.12. Russia GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.1.13. Rest of Europe GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
5.3.1.14. Rest of Europe GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific GMP Testing Service Market Outlook, 2019-2032
6.1. Asia Pacific GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Product Validation Testing
6.1.1.2. Bioanalytical Services
6.1.1.3. Packaging & Shelf-Life Testing
6.1.1.4. Other Services Type
6.2. Asia Pacific GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Pharmaceutical and Biopharmaceutical Companies
6.2.1.2. Medical Device Companies
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. China GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.2. China GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.1.3. Japan GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.4. Japan GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.1.5. South Korea GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.6. South Korea GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.1.7. India GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.8. India GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.1.9. Southeast Asia GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.10. Southeast Asia GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.1.11. Rest of Asia Pacific GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
6.3.1.12. Rest of Asia Pacific GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America GMP Testing Service Market Outlook, 2019-2032
7.1. Latin America GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Product Validation Testing
7.1.1.2. Bioanalytical Services
7.1.1.3. Packaging & Shelf-Life Testing
7.1.1.4. Other Services Type
7.2. Latin America GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.2.1.1. Pharmaceutical and Biopharmaceutical Companies
7.2.1.2. Medical Device Companies
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Brazil GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
7.3.1.2. Brazil GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
7.3.1.3. Mexico GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
7.3.1.4. Mexico GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
7.3.1.5. Argentina GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
7.3.1.6. Argentina GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
7.3.1.7. Rest of Latin America GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
7.3.1.8. Rest of Latin America GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa GMP Testing Service Market Outlook, 2019-2032
8.1. Middle East & Africa GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Product Validation Testing
8.1.1.2. Bioanalytical Services
8.1.1.3. Packaging & Shelf-Life Testing
8.1.1.4. Other Services Type
8.2. Middle East & Africa GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Pharmaceutical and Biopharmaceutical Companies
8.2.1.2. Medical Device Companies
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. GCC GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
8.3.1.2. GCC GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
8.3.1.3. South Africa GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
8.3.1.4. South Africa GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
8.3.1.5. Egypt GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
8.3.1.6. Egypt GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
8.3.1.7. Nigeria GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
8.3.1.8. Nigeria GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
8.3.1.9. Rest of Middle East & Africa GMP Testing Service Market by Type, Value (US$ Bn), 2019-2032
8.3.1.10. Rest of Middle East & Africa GMP Testing Service Market by End User, Value (US$ Bn), 2019-2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Eurofins Scientific
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. North American Science Associates Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Almac Group
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. PPD Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Intertek Group PLC
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Nelson Laboratories LLC
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Wuxi AppTec.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Sartorius AG
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Boston Analyticals
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Pace Analyticals
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations